Patient Selection Criteria for Different Versions of Abiraterone Acetate in mCRPC

This video segment discusses patient selection criteria for choosing between the original brand, generic, and micronized versions of abiraterone.

EP: 1.Bone Predominant mCRPC Patient Case

EP: 2.Case 1: A 68-Year-Old Man with Bone-Predominant Metastatic Castration-Resistant Prostate Cancer (mCRPC)

EP: 3.Abiraterone Acetate Versions for Treatment of mCRPC

Now Viewing

EP: 4.Patient Selection Criteria for Different Versions of Abiraterone Acetate in mCRPC

EP: 5.Assessing Treatment Efficacy: Communication with Patients and Caregivers

EP: 6.Patient with mCRPC and Hepatic Disease

EP: 7.Treatment and Co-Management of mCRPC Patients with Aggressive Disease

Video content above is prompted by the following:

• Can you share your patient selection criteria for different versions of abiraterone?

Related Videos